IntroductionDrug-induced prolongation of the heart rate-corrected QT interval (QTc) is associated with increased risk for the potentially fatal arrhythmia torsades de pointes. Due to arrhythmia risk,
Interventions: Bevacizumab is administered in 0.5mg/kg/min. Primary outcome(s): Having onset of hypersensitivity reaction or not Study Design: Single arm Non-randomized
The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. The main questions it aims to answer are: 1. what is the max
Abbreviation: NSCLC, non-small-cell lung cancer; MBC, metastatic breast cancer;1gemcitabine is used as single agent and combination therapy in two clinical trials, thus there is a total of 22 comparis